{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:30:48Z","timestamp":1792740648113,"version":"4.5.0"},"reference-count":73,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2022,1,31]]},"DOI":"10.1080\/21645515.2022.2037350","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T03:22:17Z","timestamp":1646364137000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":47,"title":["Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches"],"prefix":"10.1080","volume":"18","author":[{"given":"Judith","family":"Absalon","sequence":"first","affiliation":[{"name":"Pfizer Vaccine Research & Development","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Simon","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Research & Development","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Radley","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Research & Development","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Giardina","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Research & Development","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Koury","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Research & Development","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin U.","family":"Jansen","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Research & Development","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaliesa S.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Research & Development","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2007.05.014"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(73)80606-7"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix656"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005384"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3453"},{"key":"e_1_3_3_7_1","unstructured":"World Health Organization. Group B streptococcus vaccine: full value of vaccine assessment. 2 Nov 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240037526."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(73)80524-4"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix655"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1881"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000410380"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.02.030"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1451-5"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31821dc76f"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5430493"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix660"},{"key":"e_1_3_3_17_1","unstructured":"Centers for Disease Control and Prevention. Active bacterial core surveillance report emerging infections program network group B Streptococcus 2018. 19 May 2020. https:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/gbs18.html."},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix664"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix661"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198606263142603"},{"key":"e_1_3_3_21_1","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease-revised guidelines from CDC. 2010","volume":"59","author":"Verani JR","year":"2010","unstructured":"Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC. 2010. MMWR Recomm Rep. 2010;59:1\u201336.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806820"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.11.056"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318180b3b9"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12371"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.0593"},{"key":"e_1_3_3_27_1","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC","volume":"51","author":"Schrag S","year":"2002","unstructured":"Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51:1\u201322.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2020.1758626"},{"key":"e_1_3_3_29_1","unstructured":"Centers for Disease Control and Prevention. Evaluation and diagnosis of penicillin allergy for healthcare professionals. 31 Oct 2017. https:\/\/www.cdc.gov\/antibiotic-use\/community\/pdfs\/penicillin-factsheet.pdf."},{"key":"e_1_3_3_30_1","unstructured":"Royal College of Obstetricians & Gynecologists. Group B Streptococcal disease Early-onset (Green-top guideline no. 36). 13 Sept 2017. https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/guidelines\/gtg36\/2017."},{"key":"e_1_3_3_31_1","unstructured":"UK National Screening Committee. Group B Streptococcus. Antenatal screening programme. March 2017. https:\/\/view-health-screening-recommendations.service.gov.uk\/group-b-streptococcus\/2017."},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169101"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-015-0460-2"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2494"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30478-3"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.08.047"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/985646"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01294"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30190-1"},{"key":"e_1_3_3_40_1","unstructured":"Centers for Disease Control and Prevention. COVID-19 vaccines while pregnant or breastfeeding. 7 Oct 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/pregnancy.html."},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy838"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.07.108"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.10.3986-3993.1992"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1021\/cb400423g"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017861"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.05.012"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz062"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197604012941404"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit549"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1086\/323350"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.45.3.618-624.1984"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.5.2186-2192.1998"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1086\/315839"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1086\/382193"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1086\/314574"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00353-0"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119042"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001190"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz737"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00152-3"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix666"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.05.039"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.019"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.056"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw377"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00230-5"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1086\/422756"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1873"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2001.00135.x"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.2202\/1557-4679.1115"},{"key":"e_1_3_3_71_1","unstructured":"Food and Drug Administration (FDA). Center for Biologics Evaluation and Research (CBER). Approaches for demonstrating effectiveness of group B streptococcus (GBS) vaccines intended for use in pregnant women to protect the newborn infant. 152nd meeting of the vaccines and related biological products advisory committee (VRBPAC). 17 May 2018. https:\/\/www.fda.gov\/media\/113958\/download."},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123014"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152524"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00131-10"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2037350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T18:36:26Z","timestamp":1744050986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2037350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,31]]}},"alternative-id":["10.1080\/21645515.2022.2037350"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2037350","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2037350"}}